Prognostic Factors in Aggressive Non‐Hodgkin's Lymphomas-Reference-Cited by-同舟云学术

Prognostic Factors in Aggressive Non‐Hodgkin's Lymphomas

Published:1998-06 Issue:3 Volume:3 Page:189-197
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:The Oncologist

Author:

Nicolaides Costas¹,Dimou Sofia²,Pavlidis Nicholas¹

Affiliation:

1. Oncology Department;

2. Pathology Department, Ioannina University Hospital, University of Ioannina, Ioannina, Greece

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.3-3-189

Reference89 articles.

1. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

2. National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

3. CHOP is curative in thirty percent of patients with diffuse large cell lymphoma: a twelve year Southwest Oncology Group follow up;Coltman CA;Proc Am Soc Clin Oncol,1986

4. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).

5. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contributions of cancer treatment, comorbidities, and obesity to aging-related disease risks among non-Hodgkin lymphoma survivors;Cancer Causes & Control;2022-11-22

2. Patient–Proxy Agreement Regarding Health-Related Quality of Life in Survivors with Lymphoma: A Propensity-Score Matching Analysis;Cancers;2022-01-25

3. Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment;Current Pharmaceutical Design;2021-04-02

4. Changes in Incidence and Survival by Decade of Patients With Primary Colorectal Lymphoma: A SEER Analysis;Frontiers in Public Health;2020-10-16

5. Clinical Predictors and Prognostic Model for Pediatric Lymphoblastic Lymphoma Treated With Uniform BFM90 Protocol: A Single-Center Experience of 65 Patients From Asia;Clinical Lymphoma Myeloma and Leukemia;2019-06